Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GALR1 | P47211 | 4/20 | 0.42 |
| ▸ | APP | P05067 | 2/20 | 0.41 |
| ▸ | GALR2 | O43603 | 4/20 | 0.39 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | BCL6 | P41182 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CDK4 | P11802 | 1/20 | 0.36 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.36 |
| ▸ | CCND1 | P24385 | 1/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4832502 | 0.95 | GALR1 (0.45) | GALR1GALR2SOS1MAPK1BCL6 | |
| SCHEMBL5434500 | 0.91 | GALR1 (0.42) | GALR1GALR2SOS1MAPK1MEN1 | |
| SCHEMBL6207968 | 0.91 | GALR1 (0.42) | GALR1GALR2SOS1MAPK1CDK1 | |
| SCHEMBL4832251 | 0.90 | GALR1 (0.42) | GALR1GALR2MAPK1BCL6CDK1 | |
| SCHEMBL5553430 | 0.90 | GALR1 (0.41) | GALR1GALR2SOS1MAPK1CDK1 | |
| SCHEMBL5031363 | 0.89 | GALR1 (0.50) | GALR1GALR2SOS1MAPK1CDK1 | |
| SCHEMBL6013841 | 0.89 | GALR1 (0.44) | GALR1GALR2MAPK1BCL6MAPT | |
| SCHEMBL4832646 | 0.89 | GALR1 (0.44) | GALR1GALR2MAPK1BCL6MAPT | |
| SCHEMBL5553410 | 0.89 | GALR1 (0.41) | GALR1GALR2SOS1MAPK1CDK1 | |
| SCHEMBL4829617 | 0.89 | GALR1 (0.44) | GALR1GALR2MAPK1BCL6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335770-B2 | Triazine compounds and their analogs, compositions, and methods | REDDY U5 THERAPEUTICS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-20050227983-A1 | Triazine compounds and their analogs, compositions, and methods | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227983-A1 | Triazine compounds and their analogs, compositions, and methods | MYLK, SMAD3, GID4 | GALR1 1307/4885APP 2043/4885GALR2 1003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.